Grand Yangtze Capital
Overview
Grand Yangtze Capital is a Shanghai-based private equity firm specializing in early-stage investments across sectors such as consumer goods, clean tech, business services, energy, technology, healthcare, and manufacturing within China. The firm manages both private equity and venture capital funds, focusing on growth and expansion-stage enterprises. The firm's investment strategy encompasses a broad range of industries, including consumer goods, clean tech, business services, energy, technology, healthcare, and manufacturing. They target early-stage, growth, and late-stage companies, aiming to support their development and expansion within China. Grand Yangtze Capital has a track record of over 40 investments, with several companies achieving public listings or undergoing mergers and acquisitions. Their portfolio includes notable companies such as Sino-Crystal, Shuanghuan, Hainan Rubber, HLBN, ZMJ, China UMS, ZBT Pharma, ELLASSAY, B-Soft, Guochuang Software, YMatou, Pharma Block, and others. This demonstrates their active role in fostering the growth of diverse enterprises across multiple sectors in China.
Portfolio Companies
Reach Grand Yangtze Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Grand Yangtze Capital
What sectors does Grand Yangtze Capital invest in?
Grand Yangtze Capital invests in Technology, Healthcare, Energy, Consumer Goods, Business Services and Manufacturing, and is based in Shanghai, China. Grand Yangtze Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Grand Yangtze Capital invest at?
Grand Yangtze Capital backs companies at Early Stage, Growth and Late Stage.
Which regions does Grand Yangtze Capital invest in?
Grand Yangtze Capital invests across China.
What companies has Grand Yangtze Capital invested in?
Grand Yangtze Capital's portfolio includes China UMS, Ymatou, Sino-Crystal, Shuanghuan, Hainan Rubber, HLBN, ZMJ and ZBT Pharma.
Last updated · Source: ConnectSafely investor database



